We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Ultra-Rapid Test Helps Identify Cancerous Cells in Real Time

Surgeons performing surgery.
Credit: iStock

Surgical precision in brain tumor removal may soon be enhanced by genetic data, thanks to a new technology developed at NYU Langone Health. Ultra-rapid droplet digital PCR (UR-ddPCR) can identify cancer cell mutations in real time, delivering results in just 15 minutes with high sensitivity.


In this interview, Dr. Gilad Evrony discusses how UR-ddPCR compares to standard techniques, its current limitations and its potential to guide more informed surgical decisions. He also outlines how the technology could be adapted for use in other cancers and clinical settings.

Sponsored by

View this Article for FREE Now!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.